Immunogenicity Induced by COVID-19 Vaccines in Mexican Population: mRNA Expression for IgG Anti-spike
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 80
- 试验地点
- 1
- 主要终点
- Immunogenicity induced by COVID-19 vaccines in Mexican population
研究概览
简要总结
To determine the gene expression of anti-spike IgG through PCR-RT in patients vaccinated with the 4 types of vaccines available in Mexico Oxford/AstraZeneca (ChAdOx1 nCoV-19), Centro Nacional Gamaleya (Sputnik V), Pfizer/BioNTech (BNT162b2) and Sinovac (CoronaVac).
详细描述
80 subjects with full vaccination schedule will be included, 20 per group To know the gene expression of IgG anti-spike through PCR-RT in patients vaccinated with the 4 types of vaccines available in Mexico Oxford/AstraZeneca (ChAdOx1 nCoV-19), Centro Nacional Gamaleya (Sputnik V), Pfizer/BioNTech (BNT162b2) and Sinovac (CoronaVac).
研究设计
- 研究类型
- Observational
- 观察模型
- Other
- 时间视角
- Prospective
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Mexican people.
- •Over 18 years of age.
- •With complete vaccination schedule against COVID-
- •Allowing peripheral blood samples to be taken.
- •To sign an informed consent form.
- •To agree to participate in the protocol.
排除标准
- •Persons with incomplete vaccination schedule against COVID-
- •Persons who have 30 +/- 5 days of having completed the vaccination scheme against COVID-
- •People under treatment with any immunosuppressive drug.
- •People who refuse to sign the informed consent form.
结局指标
主要结局
Immunogenicity induced by COVID-19 vaccines in Mexican population
时间窗: 4 months
To characterize the immunogenicity induced by COVID-19 vaccines in Mexican population: mRNA expression for IgG anti-spike.
次要结局
未报告次要终点
研究者
Modesto Gómez López
Immunogenicity induced by COVID-19 vaccines in Mexican population: mRNA expression for IgG anti-spike.
National Polytechnic Institute, Mexico